• November 18-20, 2019 | Crowne Plaza Boston - Newton, Boston, MA
  • Toll Free: +1 844 395 4102

Featured SpeakersVaccines R&D-2019

Farshad Guirakhoo

Farshad Guirakhoo

Chief Scientific Officer, GeoVax, Inc.

Alexander Bukreyev

Alexander Bukreyev

Professor, Departments of Pathology and Microbiology & Immunology, University of Texas Medical Branch

Nicole Darricarrère

Nicole Darricarrère

Scientist, North America Breakthrough Lab, Sanofi US

Giulio Tarro

Giulio Tarro

Foundation de Beaumont Bonelli for cancer research, Italy

Subash C. Das

Subash C. Das

Senior Scientist, Discovery Research, Vaccine Business Unit, Takeda Pharmaceuticals

Rahul Singhvi

Rahul Singhvi

Chief Operating Officer, Takeda Vaccines, Inc

Hussein Y. Naim

Hussein Y. Naim

Professor of Virology and Immunology, General Manager, Vaccinum

James D. Cherry

James D. Cherry

Distinguished Research Professor of Pediatrics, David Geffen School of Medicine at UCLA

Trudy G. Morrison

Trudy G. Morrison

Professor, University of Massachusetts Medical School

Emanuele Montomoli

Emanuele Montomoli

Dept. of Molecular and Developmental Medicine, University of Siena

Michael Lacy

Michael Lacy

Director, Nonclinical Immunology and Bioanalysis, Emergent BioSolutions

William R. Jacobs

William R. Jacobs

Professor, Department of Microbiology & Immunology, Albert Einstein College of Medicine

Nikolai Petrovsky

Nikolai Petrovsky

Professor of Medicine, Flinders University, Australia

Xintao Hu

Xintao Hu

Research Fellow, Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute

John J.S. Cadwell

John J.S. Cadwell

CEO, FiberCEll Systems Inc.

Marylyn M. Addo

Marylyn M. Addo

University Medical Center Hamburg- Eppendorf, Germany

Denise Faustman

Denise Faustman

Physician, Harvard Medical School and Massachusetts General Hospital

Daniel H. Zimmerman

Daniel H. Zimmerman

Senior Vice President R&D, CEL-SCI Corporation

Tai June Yoo

Tai June Yoo

CEO/Founder& Director, StemGen Inc

Punnee Pitisuttithum

Punnee Pitisuttithum

Director, Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University

Edith Jasny

Edith Jasny

Senior Scientist, CureVAc AG
Germany

Laura Nguyen

Laura Nguyen

Scientist, NA Breakthrough Lab, Sanofi US

Chih-Jen Wei

Chih-Jen Wei

Director, NA Breakthrough Lab, Sanofi US

Stefan Koester

Stefan Koester

Scientist, NA Breakthrough Lab, Sanofi US

Ling Chen

Ling Chen

Visiting Investigator, Guangzhou Institute of Biomedicine and Health

Trudy Morrison

Trudy Morrison

Professor, University of Massachusetts Medical School

Ying Wang

Ying Wang

Senior Scientist
Codagenix

Gilberto Filaci

Gilberto Filaci

University of Genoa
Italy

Jerald C. Sadoff

Jerald C. Sadoff

Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.

Adan Rios

Adan Rios

Professor, Oncology Division, Department of Internal Medicine, UT McGovern Medical School

Thomas S Uldrick

Thomas S Uldrick

Deputy Head, Global Oncology, Associate Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Femke Hoeksema

Femke Hoeksema

Senior Scientist and Team Leader, Batavia Biosciences BV

Teri Heiland

Renhuan Xu

Senior Scientist
Immunomic Therapeutics

Athanasia A. Anagnostou

Athanasia A. Anagnostou

Senior Director of Corporate Development, Immunomic Therapeutics

Elizabeth Parzych

Elizabeth Parzych

Postdoctoral Fellow, The Wistar Institute

Daron Freedberg

Daron Freedberg

Principal Investigator, CBER/FDA

Rosemarie Mason

Rosemarie Mason

Staff Scientist, Vaccine Research Center/NIAID/NIH

Daniel W. Kulp

Daniel W. Kulp

Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute

Kristl Pacheco

Kristl Pacheco

Sanofi Pasteur
US

Rachel Mitrovich

Rachel Mitrovich

Guest Researcher, Global Health, Boston University School of Public Health

Kevin P. Killeen

Kevin P. Killeen

Chief Scientific Officer, Matrivax R&D Corp

Christopher Gill

Christopher Gill

Associate Professor, Global Health, Boston University School of Public Health

Francisco Diaz-Mitoma

Francisco Diaz-Mitoma

Chief Medical Officer, VBI Vaccines, Inc.

Linong Zhang

Linong Zhang

Director
Sanofi Pasteur

Ruth Ruprecht

Ruth Ruprecht

Leader, Director, Texas Biomed AIDS Research Program

M. Javad Aman

M. Javad Aman

President and Chief Scientific Officer, Integrated BioTherapeutics, Inc.

Jenny Hendriks

Jenny Hendriks

Head Vaccine Biomarkers, Janssen Vaccines & Prevention

Luciana C C Leite

Luciana C C Leite

Vaccine Development Laboratory, Instituto Butantan

Gabriel Gutierrez

Gabriel Gutierrez

Director of Biologics, Explorations in Global Health (ExGloH), Leidos

Jacqueline M Hirth

Jacqueline M Hirth

Assistant Professor, Obstetrics and Gynecology, University of Texas Medical Branch

Michael G. Hanna Jr

Michael G. Hanna Jr

Founder and Chairman Emeritus, Vaccinogen Inc.

Jason Paragas

Jason Paragas

Lawrence Livermore National Laboratory

Geert Vanden Bossche

Geert Vanden Bossche

Biotech/Vaccine consultant
Belgium

Michael W Pride

Michael W Pride

Exec. Director / Clinical and Diagnostic Assay Development
Pfizer Vaccines Research and Development

Daniel Wolfe

Daniel Wolfe

Health Scientist
Biomedical Advanced Research & Development Authority

Antje Heit

Antje Heit

Senior Staff Scientist
Vaccine and Infectious Disease Division, FHCRC

Juine Ruey Chen

Juine Ruey Chen

Vaccine R&D Director
RH Biopharma

Teketay Wassie

Teketay Wassie

Research Fellow
Huazhog Agricultural University, China

Rafael Harpaz

Rafael Harpaz

CAPT (Ret.), USPHS, Guest Researcher, Division of Viral Diseases, CDC

Andrew Lees

Andrew Lees

Scientific Director
Fina BioSolutions

Spyros Kalams

Spyros Kalams

Principal Investigator, HIV Clinical Trials Unit, Vanderbilt University Medical Center

Jiang Zhu

Jiang Zhu

Associate Professor, Integrative Structural and Computational Biology, The Scripps Research Institute

Melissa Vrohlings

Melissa Vrohlings

Senior Scientist in Immuno-Oncology,
Virometix AG

Frederic Deschamps

Frederic Deschamps

Department of Occupational Health,
REIMS

Joseph Campo

Joseph Campo

Director of Operations
Antigen Discovery Inc.

Magdalena E. Sobieszczyk

Magdalena E. Sobieszczyk

Associate Professor of Medicine
Columbia University

Frederic Tangy

Frederic Tangy

Member: Head of Structure
Institut Pasteur, CNRS

Alexandre LE VERT

Alexandre LE VERT

Executive Chairman &
Co-Founder, OSIVAX

Drew Weissman

Drew Weissman

Professor of Medicine, University of Pennsylvania

Marie-Claire Gauduin

Marie-Claire Gauduin

Associate Professor | Disease Intervention & Prevention, Texas Biomedical Research Institute

Russell Johnson

Russell Johnson

Local Head - US, Global Discovery Support and New Technology, Technical R&D
GSK Vaccines

Robert L. Hunter

Robert L. Hunter

Distinguished Professor and Chairman, Department Of Pathology and Laboratory Medicine University of Texas Health Science Center at Houston

Richard Wyatt

Richard Wyatt

Professor, IAVI NAC at The Scripps Research Institute

Patrick R Mahy

Patrick R Mahy

Business Development Manager, Sciensano

Shahin Gharakhanian

Shahin Gharakhanian MD, Principal & CMO

Vaccine Clinical Development, SG MD Consulting LLC, CIC Cambridge MA

Jorge Flores

Jorge Flores

Global Head, Clinical, Center for Vaccine Access and Delivery, PATH

Yingxia Wen

Yingxia Wen

Head of Biochemistry, Seqirus

Ethan Settembre

Ethan Settembre

VP, Head of Research, Seqirus

Pirada Suphaphiphat

Pirada Suphaphiphat

Head of Microbial and Molecular Biology, Seqirus

Hui Liu

Hui Liu

Head of Formulation, Seqirus

Giuseppe Palladino

Giuseppe Palladino

Head of Serology
Seqirus

Gib Otten

Gib Otten

Head of Immunology, Seqirus

Ned Music

Ned Music

Investigator, Research Serology, Seqirus

Patricia Jorquera

Patricia Jorquera

Investigator, Research Serology, Seqirus

Cheng Chang

Cheng Chang

Investigator, Microbial and Molecular Biology, Seqirus

Yuhong Xie

Yuhong Xie

Scientist III, Biochemistry, Seqirus

Joseph Bazzill

Joseph Bazzill

Investigator, Formulation, Seqirus

Samuel Amoah

Samuel Amoah

Investigator
Immunology
Seqirus

Yoshihiro Miyahara

Yoshihiro Miyahara

Associate Professor, Immuno-Gene therapy, Mie University Graduate School of Medicine

Hiroshi Shiku

Hiroshi Shiku

Professor and Chairman, Immuno-gene therapy, Mie University Graduate School of Medicine

Naozumi Harada

Naozumi Harada

CEO & CTO
United Immunity
Co., Ltd.

Xiaowu Pang

Xiaowu Pang

Assistant Professor
Howard University

Hong-Jin Kim

Hong-Jin Kim

Director of Research, POSVAX CO., LTD.

Shivani Verma

Shivani Verma

Defence Institute of Physiology and Allied Sciences, India

Pankaj Agrawal

Pankaj Agrawal

Associate Scientist
Sanofi

Chit Laa Poh

Chit Laa Poh

Distinguished Professor & Head, Centre for Virus and Vaccine Research, Sunway University

Shufeng Liu

Shufeng Liu

U.S. Food and Drug Administration

Marzia Monica Giuliani

Marzia Monica Giuliani

Head of Preclinical Evidence Generation and Bioassays, GSK Vaccines

Katelyn McLaughlin

Katelyn McLaughlin

Associate R&D Scientist | Beyond CHO Media Development | Upstream R&D, Millipore Sigma

Claudia Giorgina Vitali

Claudia Giorgina Vitali

Senior Toxicologist, GSK Vaccines

Nicholas Jackson

Nicholas Jackson

VP Head of Global Research, Sanofi

Joseph Vetro

Joseph Vetro

Associate Professor, Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center

Jeronimo Carnes Sanchez

Jeronimo Carnes Sanchez

LABORATORIOS LETI
Spain

Kathleen  Hefferon

Kathleen Hefferon

Postdoctoral Fellow, Cornell University

Kathryn M. Kosuda

Kathryn M. Kosuda

Chief Scientific Officer, Vaxess Technologies, Inc.

M. Gordon Joyce

M. Gordon Joyce

Chief, Structural Biology Section, Walter Reed Army Institute of Research

Ruxandra Draghia-Akli

Ruxandra Draghia-Akli

VP, Vaccines Public Health and Scientific Affairs, Merck